Xiaoping Jin
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 41
- Cancer Immunotherapy and Biomarkers 28
- HER2/EGFR in Cancer Research 6
- Colorectal Cancer Treatments and Studies 5
- Lung Cancer Research Studies 4
-
- Lung Cancer Treatments and Mutations 9
- Ferroptosis and cancer prognosis 7
- Co-authors
- Ashok Gupta (23 shared papers)Bradley P. Carlin (3 shared papers)Sudipto Banerjee (2 shared papers)Christophe Massard (4 shared papers)Peter H. O’Donnell (4 shared papers)Yong Ben (10 shared papers)Marlon C. Rebelatto (9 shared papers)Joyce Antal (10 shared papers)
- Journals
- Journal of Clinical Oncology (31 papers)Cancer Research (4 papers)Endocrine Practice (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Archives of Pathology & Laboratory Medicine (1 paper)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Xiaoping Jin
69 papers receiving 2.7k citations
Xiaoping Jin's Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 1.5k
- Immunology 493
- Surgery 874
- Hepatology 123
- Statistics and Probability 141
Countries citing papers authored by Xiaoping Jin
This map shows the geographic impact of Xiaoping Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Jin more than expected).
Fields of papers citing papers by Xiaoping Jin
This network shows the impact of papers produced by Xiaoping Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Jin. The network helps show where Xiaoping Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma Hit paper breakdown → | 2017 | 665 |
| 2 | Safety and Efficacy of Durvalumab (MEDI4736), an Anti–Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer Hit paper breakdown → | 2016 | 663 |
| 3 | 2005 | 150 | |
| 4 | 2016 | 137 | |
| 5 | 2017 | 121 | |
| 6 | 2017 | 114 | |
| 7 | 2007 | 75 | |
| 8 | 2013 | 73 | |
| 9 | 2017 | 58 | |
| 10 | 2017 | 45 | |
| 11 | 2019 | 38 | |
| 12 | 2015 | 33 | |
| 13 | 2010 | 31 | |
| 14 | 2021 | 31 | |
| 15 | 2010 | 31 | |
| 16 | 2024 | 26 | |
| 17 | Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial Hit paper breakdown → | 2025 | 22 |
| 18 | 2018 | 19 | |
| 19 | 2016 | 19 | |
| 20 | 2014 | 19 |
About Xiaoping Jin
Xiaoping Jin is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 71 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (28 papers), Bladder and Urothelial Cancer Treatments (13 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Lung Cancer Treatments and Mutations (9 papers), Ferroptosis and cancer prognosis (7 papers), HER2/EGFR in Cancer Research (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Lung Cancer Research Studies (4 papers). The work is most often cited by research in Oncology (1.5k citations), Immunology (493 citations), Surgery (874 citations), Hepatology (123 citations) and Statistics and Probability (141 citations). Xiaoping Jin has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Ashok Gupta, Bradley P. Carlin, Sudipto Banerjee, Christophe Massard, Peter H. O’Donnell, Yong Ben, Marlon C. Rebelatto, Joyce Antal, John A. Blake-Haskins and Neil H. Segal. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Endocrine Practice, Clinical Pharmacology & Therapeutics and Archives of Pathology & Laboratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.